Remdesivir india

Ended Definitive Contract Awarded

Contract number
75A50121C00050
Awardee
Awarding agency
Obligated
$48,647,637

Award facts

Contract value 100% obligated
$48,647,637.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Not Competed · 1 offer Only One Source
Pricing
Firm Fixed Price
Place of performance
Carrollton, TX 75010, USA
National interest action
Coronavirus COVID-19

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Modification $49,341,250
Other Administrative Action P00001 · Remdesivir india deobligate $693,613.00 -$693,613

About this award

The Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response awarded a $48.6 million firm fixed price definitive contract to ASD Specialty Healthcare LLC, a division of Amerisourcebergen Specialty Group LLC and subsidiary of Amerisourcebergen Corporation, to deliver remdesivir for the treatment of COVID-19. Performance will take place in Carrollton, Texas over a period of five days from April 30 to May 5, 2021. The contract was awarded under the National Interest Action Code for coronavirus and will provide the antiviral drug remdesivir to support the federal government's response to the COVID-19 pandemic.

Quick answers

Who was awarded contract 75A50121C00050?

75A50121C00050 was awarded to ASD Specialty Healthcare, LLC by Office of the Assistant Secretary for Preparedness and Response (Department of Health and Human Services) on April 30, 2021.

How much is contract 75A50121C00050 worth?

The government has obligated $48,647,637 on 75A50121C00050.

Was contract 75A50121C00050 competed?

The extent of competition for 75A50121C00050 was not competed. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award